Overexpression and ratio disruption of ΔNp63 and TAp63 isoform equilibrium in endometrial adenocarcinoma: correlation with obesity, menopause, and grade I/II tumors
- PMID: 22441934
- DOI: 10.1007/s00432-012-1200-8
Overexpression and ratio disruption of ΔNp63 and TAp63 isoform equilibrium in endometrial adenocarcinoma: correlation with obesity, menopause, and grade I/II tumors
Abstract
Purpose: p63 plays an important role in several intracellular processes such as transcription activation and apoptosis. p63 has two N-terminal isoforms, TAp63 and ΔNp63. TAp63 isoform has p53-like functions, while ΔNp63 acts as a dominant negative inhibitor of the p53 family and is considered oncogenic. Although p63 and its isoforms are overexpressed in a wide variety of human malignancies such as cervical, head and neck, and lung cancer, their role in endometrial carcinoma has not been investigated.
Methods: We measured by quantitative real-time polymerase chain reaction the mRNA expression of TAp63 and ΔNp63 in a series of 20 endometrioid adenocarcinomas paired with adjacent normal tissue.
Results: TAp63 isoform exhibited 1.8-fold overexpression in malignant samples, while ΔNp63 was 4.3-fold overexpressed in cancer specimens. Further analysis revealed that the ΔN/TA isoform ratio shifted from 0.5 in normal samples to 1.2 in tumor specimens. Statistical analysis also revealed an association of TAp63 expression with high body mass index (p = 0.034), late menopause (p = 0.020), and lower tumor grade (p = 0.034). ΔNp63 was also correlated with grade I/II tumors (p = 0.044).
Conclusions: These results indicate that both p63 isoforms and especially ΔNp63 play an important role in the development and progression of grade I/II endometrial adenocarcinoma, especially in obese and late-menopause women.
Similar articles
-
ΔNp63 to TAp63 expression ratio as a potential molecular marker for cervical cancer prognosis.PLoS One. 2019 Apr 11;14(4):e0214867. doi: 10.1371/journal.pone.0214867. eCollection 2019. PLoS One. 2019. PMID: 30973901 Free PMC article.
-
p63 and p73 isoform expression in non-small cell lung cancer and corresponding morphological normal lung tissue.J Thorac Oncol. 2011 Mar;6(3):473-81. doi: 10.1097/JTO.0b013e31820b86b0. J Thorac Oncol. 2011. PMID: 21289519
-
Expression and regulation of the ΔN and TAp63 isoforms in salivary gland tumorigenesis clinical and experimental findings.Am J Pathol. 2011 Jul;179(1):391-9. doi: 10.1016/j.ajpath.2011.03.037. Epub 2011 May 7. Am J Pathol. 2011. PMID: 21703418 Free PMC article.
-
TAp63 and DeltaNp63 in cancer and epidermal development.Cell Cycle. 2007 Feb 1;6(3):274-85. doi: 10.4161/cc.6.3.3797. Epub 2007 Feb 3. Cell Cycle. 2007. PMID: 17264681 Review.
-
[The two faces of p63, Janus of the p53 gene family].Med Sci (Paris). 2012 Apr;28(4):381-7. doi: 10.1051/medsci/2012284015. Epub 2012 Apr 25. Med Sci (Paris). 2012. PMID: 22549865 Review. French.
Cited by
-
Differentially Expressed Genes in EEC and LMS Syndromes.PLoS One. 2015 Jun 15;10(6):e0129432. doi: 10.1371/journal.pone.0129432. eCollection 2015. PLoS One. 2015. PMID: 26075610 Free PMC article.
-
Interleukin-17A mediates tobacco smoke-induced lung cancer epithelial-mesenchymal transition through transcriptional regulation of ΔNp63α on miR-19.Cell Biol Toxicol. 2022 Apr;38(2):273-289. doi: 10.1007/s10565-021-09594-0. Epub 2021 Apr 3. Cell Biol Toxicol. 2022. PMID: 33811578
-
ΔNp63 to TAp63 expression ratio as a potential molecular marker for cervical cancer prognosis.PLoS One. 2019 Apr 11;14(4):e0214867. doi: 10.1371/journal.pone.0214867. eCollection 2019. PLoS One. 2019. PMID: 30973901 Free PMC article.
-
The dual role of p63 in cancer.Front Oncol. 2023 Apr 27;13:1116061. doi: 10.3389/fonc.2023.1116061. eCollection 2023. Front Oncol. 2023. PMID: 37182132 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous